Moreover, LSD1 co-localizes with N-MYC at the promoter of CDKN1A (p21CIP) and Clusterin (CLU), two tumor suppressor genes, thereby functionally cooperating with N-MYC in neuroblastoma initiation and progression [86]. The gene discussed is MYCN; the disease is neuroblastoma.